治療中の小細胞肺がんの進化軌跡
Julie George1,2, Lukas Maas3, Nima Abedpour3,4,5
1Department of Translational Genomics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. jgeorge@uni-koeln.de.
Nature
|March 14, 2024
まとめ
小細胞肺がん (SCLC) のゲノム進化は,化学療法後の急速な再発を引き起こします. これらの進化パターンを理解することは この攻撃的な癌の治療法の開発の鍵です
科学分野:
- 腫瘍学
- ゲノミクス
- 癌 の 進化
背景:
- 小細胞肺がん (SCLC) は化学療法に対して非常に敏感ですが,しばしば急速に再発します.
- SCLCの治療への反応と再発の背後にある進化的メカニズムは不明である.
研究 の 目的:
- 化学療法と免疫療法中のSCLCのゲノム進化過程を調査する.
- 再発のクローン起源と,治療に対する感受性や耐性に関連したゲノムパターンを特定する.
主な方法:
- 診断時および治療中の65人のSCLC腫瘍の多領域シーケンシング.
- 治療中の腫瘍の進化を再現するための 系統遺伝分析
主要な成果:
- 化学療法は,SCLCにおける重要なゲノム内異質性と空間的なクローン多様性を誘発した.
- 腫瘍の再発は 枝分かれした進化と 祖先のクローンの再拡大によって引き起こされました
- TP53/RB1の変異は共通の祖先の出来事であり,MYCの増幅はしばしばサブクローンであった.
- 特定のTP53変異と共変異 (TP73,CREBBP/ EP300,FMN2) は,より短い再発時間と相関しています.
結論:
- 共通の祖先のクローンは,SCLCの再発時のクローンの多様性の主要な源である.
- 治療中のゲノム進化は,SCLCの感受性と抵抗性の主要なパターンを明らかにします.
- これらの進化的動態を理解することで,SCLCの将来の治療戦略に情報を与えることができます.
さらに関連する動画
09:38Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
8.0K
06:11Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
9.8K
関連する概念動画
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
02:53Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K